ReviewTherapeutics and clinical risk management2023

Empagliflozin in Adults with Chronic Kidney Disease (CKD): Current Evidence and Place in Therapy.

Gates B Colbert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.